Schwarz Pharma’s Neupro Patch Gets FDA Nod For Early Parkinson’s Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
Company plans to submit an sNDA for the dopamine agonist for advanced Parkinson’s by the end of the year.